News

Fierce Biotech2h
Frazier Life Sciences raises $1.3B for latest early-stage biotech venture fund
Last week, Australian life sciences venture capital firm Brandon Capital closed its largest fund yet, raising A$439 million ...
Fierce Biotech2h
AbbVie crowns Gilgamesh its next M&A target with $1B buyout talks: report
AbbVie has reportedly added Gilgamesh Pharmaceuticals to its shopping list. | AbbVie has reportedly added Gilgamesh ...
Fierce Biotech55m
Nuvectis axes ovarian cancer program after seeing phase 1b data
NXP800, a GCN2 kinase activator, has been on shaky ground since a data drop in November revealed a lack of efficacy. Seeking to improve outcomes, Nuvectis turned its attention to a new cohort of ...
Fierce Biotech23h
FDA misses IND deadline for Coya’s ALS asset, cites lack of resources
The FDA has missed the date for Coya Therapeutics’ investigational new drug (IND) application, citing a lack of resources and ...
Fierce Biotech19h
NextCure antibody strengthens bones in mice with rare brittle bone disease
Maryland-based biotech NextCure is looking for partners to advance a candidate for the currently incurable rare disease ...
Fierce Biotech22h
Cardiosense scores FDA clearance for wearable sensor that monitors heart function
Medical AI company Cardiosense has claimed an FDA clearance for its CardioTag device, a wearable sensor that provides a ...